Key PointsNovo Nordisk was first to market with a GLP-1 weight-loss shot and pill.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.
Veytics Intelligence
Novo Nordisk's Wegovy Pill Has Topped 5 Million Prescriptions. Is the Stock a Buy Now?
